Published in Mol Genet Metab on June 17, 2015
Longitudinal Studies of Brain Structure and Function in MPS Disorders | NCT01870375
MRS to Determine Neuroinflammation and Oxidative Stress in MPS I | NCT03576729
Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI. Mol Genet Metab Rep (2016) 0.77
A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II. Mol Genet Metab Rep (2016) 0.76
Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I. Am J Med Genet A (2017) 0.75
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome. Mol Genet Metab Rep (2017) 0.75
FreeSurfer. Neuroimage (2012) 8.37
Structural and functional brain development and its relation to cognitive development. Biol Psychol (2000) 5.40
Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron (2010) 3.74
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A (2003) 2.96
Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics (2009) 2.79
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Brain and spinal MR imaging findings in mucopolysaccharidoses: a review. AJNR Am J Neuroradiol (2012) 1.75
Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab (2007) 1.71
Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer (2006) 1.64
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr (2005) 1.63
Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genet Med (2003) 1.62
Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis (1995) 1.62
Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology (2004) 1.61
The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant (2008) 1.60
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant (2003) 1.50
Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev Med Child Neurol (2007) 1.46
Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant (2007) 1.42
Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop (2003) 1.37
Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol (2004) 1.34
Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am (2010) 1.21
Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer (2009) 1.16
The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis (1995) 1.14
Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology (2007) 1.09
Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I. J Inherit Metab Dis (2010) 1.08
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients. J Pediatr (2009) 1.07
Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metab Brain Dis (2012) 1.01
Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I. Comp Med (2013) 1.00
Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Acta Paediatr (2008) 0.99
Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed. J Inherit Metab Dis (2008) 0.98
Early treatment is associated with improved cognition in Hurler syndrome. Ann Neurol (2014) 0.97
Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy. Clin Chim Acta (2007) 0.95
High-dose enzyme replacement therapy in murine Hurler syndrome. Mol Genet Metab (2013) 0.94
Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr Suppl (2008) 0.93
Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol (2000) 0.93
An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol Genet Metab (2012) 0.90
Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome. Mol Genet Metab (2013) 0.90
Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr (2012) 0.87
White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood. Neuropsychiatr Dis Treat (2008) 0.80